Witnessing the stock’s movement on the chart, on Wednesday, Kiniksa Pharmaceuticals International Plc (NASDAQ: KNSA) set off with pace as it heaved 5.84% to $28.8, before settling in for the price of $27.21 at the close. Taking a more long-term approach, KNSA posted a 52-week range of $17.82-$30.69.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 27.38%. Meanwhile, its Annual Earning per share during the time was 27.38%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 227.96%. This publicly-traded company’s shares outstanding now amounts to $42.16 million, simultaneously with a float of $40.47 million. The organization now has a market capitalization sitting at $2.10 billion. At the time of writing, stock’s 50-day Moving Average stood at $27.52, while the 200-day Moving Average is $23.20.
Kiniksa Pharmaceuticals International Plc (KNSA) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – Specialty & Generic industry. Kiniksa Pharmaceuticals International Plc’s current insider ownership accounts for 44.54%, in contrast to 55.05% institutional ownership. According to the most recent insider trade that took place on Jun 16 ’25, this organization’s CHIEF OPERATING OFFICER sold 17,300 shares at the rate of 28.28, making the entire transaction reach 489,244 in total value, affecting insider ownership by 61,563.
Kiniksa Pharmaceuticals International Plc (KNSA) Earnings and Revenue Records
Kiniksa Pharmaceuticals International Plc’s EPS increase for this current 12-month fiscal period is 227.96% and is forecasted to reach 1.31 in the upcoming year.
Kiniksa Pharmaceuticals International Plc (NASDAQ: KNSA) Trading Performance Indicators
Let’s observe the current performance indicators for Kiniksa Pharmaceuticals International Plc (KNSA). It’s Quick Ratio in the last reported quarter now stands at 3.43. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.37. Similarly, its price to free cash flow for trailing twelve months is now 48.06.
In the same vein, KNSA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.24, a figure that is expected to reach 0.18 in the next quarter, and analysts are predicting that it will be 1.31 at the market close of one year from today.
Technical Analysis of Kiniksa Pharmaceuticals International Plc (KNSA)
Going through the that latest performance of [Kiniksa Pharmaceuticals International Plc, KNSA]. Its last 5-days volume of 0.76 million indicated improvement to the volume of 0.7 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 46.64% While, its Average True Range was 58.39%.
Raw Stochastic average of Kiniksa Pharmaceuticals International Plc (KNSA) in the period of the previous 100 days is set at 84.80%, which indicates a major rise in contrast to 79.58% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.97 that was lower than 1.00 volatility it exhibited in the past 100-days period.
